At another stop on the Road to 50 States, Jonathan Rigby, President, and Group CEO at Revolo Biotherapeutics, talks to Nigel about the company's mission and vision and where Revolo is stepping in to address shortcomings in therapies for autoimmune and allergic diseases.
